Mandate

Vinge advises Irisity AB (publ)

November 10, 2018 Capital Markets and Public M&A

Vinge has advised Irisity AB (publ), Nasdaq First North, in connection with a directed new issue of shares to Nordic institutional and private investors.

The subscription price of SEK 17.50 has been determined through a so called accelerated book building process. Irisity will receive approximately MSEK 25 as a result of the issue. The issue proceeds will be used, among other things, for Irisity’s development and accelerated growth by strengthening the organization through the recruitment of personnel, which can occur both through new employment and acquisition of companies with the requisite competence and thereby increasing the company’s financial flexibility and freedom of action for continued growth creation. SEB acted as financial adviser.

Vinge’s team primarily consisted of responsible partner Anders Strid, Frida Bergqvist, Wibeke Sorling and corporate assistant Camilla Andersson.

Related

Vinge has advised Investor in connection with acquisition of shares in EQT

Vinge has advised Investor in connection with an acquisition of 12,500,000 shares in EQT AB from Wallenberg Investments for a total consideration of approximately SEK 3.5 billion.
October 19, 2026

Vinge has advised Oncopeptides in connection with a directed share issue

Vinge has advised Oncopeptides in connection with a directed share issue, whereby Oncopeptides raises proceeds of SEK 100 million.
October 16, 2026

Vinge advises KGAL on its divestment of a Nordic wind portfolio to Enordic Evergreen

Vinge has advised KGAL on the divestment of a Nordic onshore wind portfolio to Enordic Evergreen.
October 14, 2026